Matias, I.
Lehmann, E. W.
Zizzari, P.
Byberg, S.
Cota, D.
Torekov, S. S.
Quarta, C. http://orcid.org/0000-0002-1352-4239
Article History
Received: 21 August 2023
Accepted: 13 October 2023
First Online: 4 November 2023
Declarations
:
: SST has received research grants and speaker fees from Novo Nordisk. EWL is employed at Novo Nordisk A/S, but not at the time of preparation of this manuscript.
: The study was approved by the ethical committee in Copenhagen (reference number: H-4-2010-134) and was performed in accordance with the Helsinki Declaration II and with ICH-GCP practice.
: Participation in the investigation was voluntary and the individuals could at any time retract their consent to participate. ClinicalTrials.gov Identifier: NCT02094183.